Confederation of Indian Industry (CII) announces its 6th International flagship summit – Pharma Summit 2008 to be held in Mumbai on September 10 2008.
The Keynote address of the Summit will be given by Dr Anbumani Ramadoss, Hon. Union Minister for Health & Family Welfare, Government of India. Dr Surinder Singh, Drugs Controller General, Government of India will also grace the occasion.
The event will witness the release of CII and KPMG report on “India Pharma Inc. – An Emerging Global Pharma Hub”.

Speaking on the occasion Mr. Jai Hiremath, Chairman, CII Pharma Summit 2008 and Vice Chairman and Managing Director, Hikal Ltd said, “Following the huge success of the earlier editions, CII is hosting the 6th edition of the Pharma Summit 2008. The aim of the summit is to identify the emerging opportunities in the industry and prepare itself to meet the new challenges in capturing these opportunities. The Summit will also focus on the specific sub-sectors such as CRAMS, Clinical research and related services, Discovery research, Biotechnology and Global generics opportunities that will enable Indian Pharmaceutical industry to emerge as the global pharma hub.”

The Summit will bring together crosscurrents of opinions, views and ideas inherent to the Pharmaceutical Industry, as it prepares to meet new challenges and imperatives. The Summit aims to build a common platform for the Indian Pharmaceutical community

Pharma Summit 2008 is supported by Bulk Drug Manufacturers Association (BDMA), Indian Chemical Council (ICC), Indian Drug Manufacturer’s Association (IDMA), Indo French Chamber of Commerce & Industry (IFCCI), Organization of Pharmaceutical Producers of India (OPPI).

Some of the Key speakers at the event would be, K Satish Reddy, Managing Director & Chief Executive Officer, Dr Reddy’s Laboratories Ltd , Banmali Agrawala, Chairman, CII Western Region and Executive Director – Strategy & Business Development, The Tata Power Company Ltd, Habil F Khorakiwala, Chairman, Wockhardt Ltd, Roger Metelerkamp, Senior Partner-Global Pharmaceutical Practice, KPMG, United Kingdom, Ranjit Shahani, Vice Chairman & Managing Director, Novartis India Ltd, Dr Swati Piramal, Director – Strategic Alliances & Communications, Piramal Healthcare Ltd, Satish Khanna, Group President, Lupin Ltd, Dr J M Khanna, Executive Director & President (Life Sciences), Jubilant Organosys Ltd, Suneela Thatte, Executive Director – Clinical Operations, Quintiles Research (India) Pvt. Ltd, Dr B Gopalan, Chief Scientific Officer & Executive Director, Orchid Pharmaceuticals Ltd, Dr Villoo Morawala Patell, Founder, Chairperson & Managing Director, Avesthagen Ltd, S V Veerramani, Vice-President, Indian Drug Manufacturers’ Association and Chairman & Managing Director, Fourrts (India) Laboratories Pvt. Ltd, Jagdish V Dore, Chief Executive Officer, Matrix Laboratories Ltd, Roger Metelerkamp, Senior Partner-Global Pharmaceutical Practice, KPMG, United Kingdom, Rajiv Shukla, Director, Investments, ICICI Venture Funds Management Co. Ltd. , Hitesh Gajaria, Executive Director, KPMG India Pvt. Ltd

Pharma Summit 2008 would cover a wide range of interesting topics to stakeholders in the industry, like India Pharma Inc. – Outsourced Research and Manufacturing Opportunity, India Pharma Inc. – Discovery Research and Biotechnology – A Long-Term Growth Strategy, India Pharma Inc. – Generics – Still in the Spotlight and leading industry players will also participate in an exclusive CEO’s Interactive Roundtable: “India Pharma Inc. : An Emerging Global Pharma Hub”.

Tags: calls, daytrading, free calls, intraday, tips

Similar Posts:

• Tata Power appoints Banmali Agrawala as E.D.,
• HUL announces key appointments
• Bilcare GCS appoints V Mangiardi as CEO
• Inclusive gwth to achieve value creation:K V Kamath
• Ranbaxy & DBT collaborate in the area of NDDR